Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TA on VBLT
I'm not a seasoned TA guy but the Full Stochastic right now is 11.60 which means this is extremely oversold with an RSI of 49..we could see this begin an uptrend soon.
Did anyone listen to the webcast today..I was in the dentist chair at 2:30
Is anyone optimistic that we could hear news tomorrow on the start of the a P3 Ovarian trial?
I read over last Q trqnscript and caught what the CEO was describing at the Nano deal and the Japan market..I also think from his description of the talks with FDA regarding the P3 Ovarian cancer study that the trial will also be getting a SPA from the FDA to follow on thr trial..hope we see another deal before the eoy..it's going to take between 6-10 months from the potential filing date of the BLA to receive a decision from the FDA regarding approval..hoping we dont have to go ahead with a secondary to help move things forward. Upfront 15M isnt that much considering the potential of VB 111. Hence the high teen % royalty on it when marketed.
A partner in China would be great IMO...Big market in China.
GLTA
BTW I finally pulled the trigger after weeks of sitting on my hands to open a position.
Sold off some EXEL to help finance that buy. Hope it was worth it. I think it just may be.
A 3000% rise on the MC would put us at 6B..that is a reasonable estimate being Roche brings that figure annually from Avastin sales. All we want to do is wet our beak..say 1B in sales a year in rGBN to start. We can worry about revenues in Ovarian, Thyroid and NSCLC later on.
Latebreaker oral presentation on interim data October 23
Cantor Fitzgerald initiates a strong buy with a PT of $16
ORAL PRESENTATION NEXT WEDNESDAY THE 18TH WITH UPDATED DATA
JPMORGAN UPS THEIR PT TO $20 TODAY
BAKER BROTHERS HAVE INCRESED THEIR HOLDINGS BY 57% DURING THE SECOND Q
MULTIPLE NDA TO BE FILED IN 2018
88% OF THE OS ARE OWNED BY INSITUTIONAL INVESTORS
2018 IS GEARING UP TO BE A GREAT YEAR FOR SHAREHOLDERS AND ESPECIALLY FOR THOSE BRAVE PATIENTS THAT ARE BEING TREATED IN THEIR MULTIPLE TRIALS
What report? 62k shares isnt that many shares..sometimes insiders have shares sold by the company the way the account is set up. My dad had shares sold every quarter when he worked for UPS. It wasnt his chlice to sell them..IMO shorts are putting the pressure on..34% short interest. One of the largest companies with that high of a % on the shares of the float. Once more data comes out especially interim data on the Unity trial the share price is going to launch..just the data that will be coming out from 5 P3 Studis will double the price by this time next year..if we get the nod on AA from the FDA who knows where the top will be.
As long as the tutes keep buying Im fine.
Today's Webcast link
http://wsw.com/webcast/ladenburg3/rxdx/index.aspx
ECTRIMS in October..ASH in December..possible news in November on FDA meeting regarding accelerated approval on Genuine study..not sure if they will presenting at SITC in November..looking for good news from October through December and beyond. Three Ph3 studies with 3 other trials getting ready to enroll. Let's hope all goes TG's way.
I meant to say October. .Lung Cancer Conference in Japan..could this have a similiar run like LOXO had?
88% Institutional Ownership with more Data coming this December.
Waiting to see if it will dip below $11..being its so heavily shorted i think they'll manipulte the price lower before mid October MS data and other catalyst. .if so I will double my position..If I'm wrong I'll pay a bit more.
I like this..the two top tutes now being NEA and Matrix..both have had great success entering early stage bios..NEA with TSRO as well as dozens more and Matrix with EXEL and INCY among others.
This company isn't one to be rating off of earnings..but I'll take $11 for a start lol..thanks for the update. Nice 300K++ block trade to end the day..also Matrix Capital upping their share count by almost 6M+ shares over the 3rd Quarter is pretty nice..Matrix was an early institutional owner in both EXEL and INCY..let's hope for a similiar run here over the next 2-3 years.
This is from 2016 but it says PT 16..all these analyst are still following the company..they all were represented on yesterday's CC..asking some valid questions.
https://www.finviz.com/quote.ashx?t=ADAP
You have good taste.
Finally remembered my password..haven't posted since 2016 on the ADA* board..my largest position..accumulating here..so many irons in the fire..if they can pull off the early approval with the FDA..Oy Vey!! I could see shares hitting $100 in the next two years..in the meantime let's just hit Raymond James PT 22..2 PH3 RMS trials upcoming followed by data in October..can't wait! Good Luck..Tom
Haven't posted here since 5/2016..still holding all my shares. Took me a good year to avg down to below $6..so many original buys at $8+..big confirmation on Adaptimmune’s science today. Looking forward to the next few years. Could be something special..James Noble mentioned that they will be presenting NY-ESO Multiple Myeloma data in December at ASH..looking forward to MAGE10 and MAGE 4 preliminary safety and efficiey data early 2018..The market share for solid tumors in just the USA is 27 billion dollars..company is positioning itself for a nice piece of that cake..good luck..-Tom
Have a few of those here..won't name them though.
This was a great post..glad I got to read it..too many other bs post seem to stay up on this board..good one rk..Turtle, listen and learn..good advice, imo
That is bs..there are many companies up over 1000% since their rs..I'll give you that 90% on the majority of bs pink slip companies and a large majority of otc companies..this is why it is important to get off this exchange in order to attract some big houses.
I'll call Monday morning. Just found his card.
Regular Nostradamus you are
I have his cellphone number if you like to call..hopefully it's not off lol..lmk
I'm glad Mayo is running these trials.
Burr, it seems to be off on my account as well. Hopefully we'll be hearing something positive about uplisting and clinical news.
Always moving at a snails pace @~
Like my snail?
I thought the conference was in Laguna Beach California
Able to get on now..didn't see any changes
Slap them 2 shares lol
Any amount of serious ask slapping should make this fly.
Suge, I'd need to see over 100k traded to think something was coming. But wait a minute..something is coming
That would be a good way to go about it BP
Why are you long if it's going down 90%?
I'd wait to load up for the bounce
I agree most otc pink slip companies have failed after a rs..have seen many do exceptionally well after a split..Priceline, Jazz Pharmaceuticals..Bluebird, AGIO, to name a few.
Come on man, there was hardly any short interest in this before the rs.
ADAP is one of my biggest holdings 22k shares long
He better for ours and the companies sake
That's looks standard to me..for legal reasons.
Big volume..lmao
Here is our new CFO's bio
https://www.linkedin.com/in/michael-j-loiacono-1689975
Thought the same here. God Bless him!
Better he torture you for a change than me buddy...lol